Navigation Links
Ambit Announces Presentations At The 55th Annual Meeting Of The American Society Of Hematology (ASH)
Date:12/9/2013

SAN DIEGO, Dec. 9, 2013 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced four oral presentations given at the 55th Annual ASH Conference in New Orleans, with data highlighting the Company's lead drug candidate, quizartinib. 

Results of the Phase 2b Randomized, Open-Label, Study of Lower Doses of Quizartinib in Subjects with FLT3-ITD Positive Relapsed Acute Myeloid Leukemia (AML): The purpose of this study is to assess the efficacy and safety of lower doses of quizartinib in the treatment of patients 18-years or older with relapsed/refractory FLT3 ITD positive AML to further improve the benefit:risk assessment of quizartinib.

This preliminary analysis is based on data available through May 28, 2013 with a minimum of eight weeks of follow up since the last subject first visit.  A total of 76 patients were enrolled from May 21, 2012 to March 27, 2013.  Median age for all patients was 55 (19-77) and 92% were FLT3-ITD(+).  35 patients remained in follow-up at the time of the analysis, and are currently censored for overall survival.  The following key information was presented:

For dose of 30mg:

  • The CRc rate was 47 percent (5 percent CR+CRp, 42 percent CRi)
  • The rate of HSCT after quizartinib use was 32 percent
  • The median overall survival was 20.7 weeks, with 16/38 patients censored as they remained in follow-up at the time of the analysis
  • Of the 12 patients who were bridged to HSCT, the median overall survival was 31 weeks
  • Grade 2 or greater QT prolongation was 11%, with a 5% grade 3 rate and no grade 4 events
  • For dose of 60mg:

  • The
    '/>"/>

  • SOURCE Ambit Biosciences
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Ambit Announces Participation At Oppenheimer 24th Annual Healthcare Conference
    2. Ambit Biosciences Provides Regulatory Update Following FDA Meeting Regarding Quizartinib (AC220)
    3. Ambit Biosciences to Announce Third Quarter 2013 Financial and Operating Results and Conference Call
    4. Ambit Biosciences Corporation Announces Second Quarter 2013 Operational Results
    5. Ambit Biosciences to Announce Second Quarter 2013 Operational Results and Conference Call
    6. Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
    7. Lo studio pubblicato su European Radiology esalta ulteriormente lutilizzo della tomosintesi al seno di Hologic nellambito dello screening del cancro con utilizzo della doppia lettura
    8. Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
    9. Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
    10. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
    11. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/31/2015)... 31, 2015  InMed Pharmaceuticals Inc. ("InMed") (CSE: ... that specializes in developing safer, more effective cannabis-based ... C. Anderson , Ph.D., to its Scientific Advisory ... who brings significant drug discovery and development expertise ... synthetic organic chemist by training with more than ...
    (Date:3/31/2015)... 31, 2015  CVS Health (NYSE: CVS ... clinical affiliations with Rush University Medical Center in ... Medical Center in Tucson, Arizona ... Care. These affiliations will help enhance access to ... these clinical affiliations, CVS Health will provide prescription ...
    (Date:3/31/2015)... 31, 2015 Biorasi , a ... strategic partnership with Medidata , the leading ... in life sciences. Offering therapeutic expertise in a ... Medidata,s electronic data capture (EDC), management and reporting ... through IV global clinical trial business. ...
    Breaking Medicine Technology:InMed Pharmaceuticals Strengthens Scientific Advisory Board 2InMed Pharmaceuticals Strengthens Scientific Advisory Board 3InMed Pharmaceuticals Strengthens Scientific Advisory Board 4CVS Health Announces New Clinical Affiliations with Leading Medical Centers in Arizona and Illinois 2CVS Health Announces New Clinical Affiliations with Leading Medical Centers in Arizona and Illinois 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 2Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 4
    ... First Disease Database for the ... VentriPoint Diagnostic System, SEATTLE, ... (KBR) enables accurate three,dimensional reconstruction of right ventricular volume and ... time and for,a lower cost than currently applied methods., ...
    ... mid 2008 with Phase 2 development ... begin late in 2008 or in early 2009 -, SAN ... announced positive results from the Phase 1,proof-of-concept trial (n=30) of NU172, ... single bolus dose with a favorable safety profile., "There is ...
    Cached Medicine Technology:Knowledge Based Reconstruction Demonstrates Accuracy in Obtaining Ventricular Volume and Function in Tetralogy of Fallot Patients, According to VentriPoint Diagnostics 2Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 2Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 3Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 4
    (Date:3/31/2015)... March 31, 2015 Dr. Poneh Ghasri, ... patients valuable savings through new Spring specials. Dr. Poneh Ghasri ... holiday celebration this year by taking advantage of discounted services ... "Spring brings together friends and loved ones that want to ... are pleased to offer solutions for a great looking smile ...
    (Date:3/31/2015)... 31, 2015 Diane Blackburn-Zambetti is ... the Mesothelioma Applied Research Foundation (Meso Foundation). Blackburn-Zambetti ... Your Health” at the BoRit Asbestos Superfund Citizen ... This program will discuss anatomy, six types of ... diseases, symptoms, treatments, prevention and proper communication with ...
    (Date:3/31/2015)... 2015 A team of Italian scientists ... anti-cancer properties, into mesothelioma cancer cells. Surviving Mesothelioma has ... its website. Click here to read it now. ... color to the spice turmeric, has limited value as ... experts at Università di Napoli Federico II are getting ...
    (Date:3/31/2015)... MO (PRWEB) March 31, 2015 The ... 2015 from 5:00 to 8:00 pm at the SpringHill Suites ... hospitals, clinics and groups with career opportunities will be attending ... will enjoy free hors d’oeuvres and raffle prize drawings. , ... says “Denver is an ideal location to hold a career ...
    (Date:3/31/2015)... The KIND LED K5 grow lights utilize ... spaces. These large yields are due to the KIND LED 3 ... LED K5 grow lights use a proprietary 12 band spectrum that ... aluminum circuit boards that are the backbone of the KIND LED ... are immense. The KIND LED K5 grow lights use about half ...
    Breaking Medicine News(10 mins):Health News:West Hollywood Cosmetic Dentist, Dr. Poneh Ghasri, is Now Offering Various Special Offers Just in Time for Spring 2Health News:Mesothelioma Foundation to speak at BoRit Asbestos Superfund Citizen Advisory Group Meeting 2Health News:New Research Reveals Novel Delivery Method for Potential Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:PracticeMatch to Host Physician Career Fair at SpringHill Suites Denver on April 8, 2015 2Health News:PracticeMatch to Host Physician Career Fair at SpringHill Suites Denver on April 8, 2015 3Health News:LED SuperNova Grow Box by SuperCloset Now Available with the KIND LED K5 Series 2
    ... Campaign Urges Patients to Take an Active Role ... 4, 2008 ,Understanding the often complex medical information ... be difficult, and the consequences of,misunderstanding this information ... is launching a national campaign to help Americans,prevent ...
    ... with periodontitis who also are infected with human ... tongue cancer, new research conducted at the University ... Periodontitis is a chronic inflammatory disease that destroys ... has been associated with various systemic diseases, including ...
    ... husband creates an extra seven hours a week of housework ... a nationally representative sample of U.S. families. , For men, ... about an hour of housework a week. , The findings ... on 2005 time-diary data from the federally-funded Panel Study of ...
    ... ACUSON P10 Delivers Faster Ultrasound Information at the First Point ... ... SAN FRANCISCO, April 4, 2008 Siemens Healthcare, (http://www.siemens.com/healthcare ... system -- at the International Conference on,Emergency Medicine (Booth #300), ...
    ... 4, 2008 Idenix,Pharmaceuticals, Inc. (Nasdaq: IDIX ) ... its Hepatitis C program at the upcoming,Canaccord Adams Hepatitis ... ET at the St. Regis Hotel in New York, ... company presentation can be,accessed under "Calendar of Events" in ...
    ... Donation Will Be Made to Middle Island Man, 32, Injured ... 4, 2008 The,following was released by The SCOOTER Store:, ... New York,City patrolman and Suffolk County parks policeman, John ... Tim Bishop (NY - 1st District), Suffolk County Legislator ...
    Cached Medicine News:Health News:'Understanding Your Caregivers' Promotes Health Literacy 2Health News:'Understanding Your Caregivers' Promotes Health Literacy 3Health News:HPV, periodontitis work in tandem to increase risk of tongue cancer 2Health News:Exactly how much housework does a husband create? 2Health News:Siemens Showcases World's First Pocket Ultrasound System at the International Conference on Emergency Medicine 2008 2Health News:Siemens Showcases World's First Pocket Ultrasound System at the International Conference on Emergency Medicine 2008 3
    ... KR-9000PW Wavefront Analyzer provides the practitioner ... visual analysis system on the market ... range auto refractometer, auto keratometer, and ... the benefits of wavefront measurement!, ,The ...
    ... The Worlds First Combination Unit, the ... Refractor, Keratometer, and Non-Contact Tonometer. By combining ... allows you to save time while providing ... trust from Marco. The M3 not only ...
    ... with a Lexan®inner calibrated flow tube has ... defects. A wide range of configurations are ... with all popular inlet connections, a 50 ... configurations. Our extra large knob coupled with ...
    ... with a Lexan®inner calibrated flow tube has ... defects. A wide range of configurations are ... with all popular inlet connections, a 50 ... configurations. Our extra large knob coupled with ...
    Medicine Products: